Evaluating the Safety of Acute Baclofen in Methadone-maintained Individuals With Opiate Dependence.

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 23, 2021

Primary Completion Date

November 11, 2022

Study Completion Date

November 11, 2022

Conditions
Addiction Opiate
Interventions
DRUG

Baclofen

Baclofen is the only selective GABA-B agonist licensed for human use. Originally developed as a potential anti-epileptic in the 1920s, it was found to have anti-spastic effects and is currently used for the treatment of spastic movement, especially in instances of spinal cord injury, spastic diplegia, multiple sclerosis, and amyotrophic lateral sclerosis.

DRUG

Vitamin D3

Placebo tablets will be vitamin D3, (colecalciferol).

Trial Locations (1)

W12 0HS

Imperial College Healthcare Trust, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT05161351 - Evaluating the Safety of Acute Baclofen in Methadone-maintained Individuals With Opiate Dependence. | Biotech Hunter | Biotech Hunter